Transcriptomics

Dataset Information

0

Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT


ABSTRACT: The goal of this study are to identify critical biomarkers distinguishing alloHSCT recipients with aGvHD from alloHSCT recipients without aGvHD in two separate cohorts. Total RNA was isolated from the peripheral blood mononucleated cells and then quantified on a Bioanalyzer. Whole transcriptome sequencing libraries (3 pairs of aGvHD and controls, 6 libraries in total) were prepared following the manufacturer’s instructions for the Whole Transcriptome Sample Prep Kit (Illumina) by GENEWIZ Company. 1148 presented significant alterations in cases with aGvHD (t test, FDR corrected P < 0.05, |fold change|>1.5). Transcriptomic pathway analysis showed that the GPL metabolism pathway was one of the most significant pathways with Bonferroni correction P value (Q value) less than 0.001, indicating that it was a critical pathway related to the development of aGvHD.

ORGANISM(S): Homo sapiens

PROVIDER: GSE131897 | GEO | 2019/10/15

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-09-01 | GSE157959 | GEO
| PRJNA545280 | ENA
2008-06-15 | E-GEOD-7510 | biostudies-arrayexpress
2022-06-11 | GSE205842 | GEO
2021-08-09 | GSE157389 | GEO
2022-01-25 | GSE165413 | GEO
2022-12-16 | GSE212162 | GEO
2023-09-14 | GSE232002 | GEO
2023-09-14 | GSE232001 | GEO
2023-09-14 | GSE231999 | GEO